πŸ‡ΊπŸ‡Έ FDA
Patent

US 8293240

Method of treating drug-resistant cancer

granted A61KA61K2039/505A61K39/39541

Quick answer

US patent 8293240 (Method of treating drug-resistant cancer) held by The Regents of the University of Colorado expires Mon Oct 18 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of Colorado
Grant date
Tue Oct 23 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 18 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
12
CPC classes
A61K, A61K2039/505, A61K39/39541, A61P, A61P35/00